Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is an extremely rare and aggressive form of kidney cancer. It is almost exclusively found in young people who carry the sickle cell gene. The sickle cell gene is particularly common in people with an African or Caribbean family background and can cause a group of inherited conditions that affect the red blood […]

read more

NHS England spotlight on specialised services – a new report

A new report from NHS England, Spotlight on specialised services, provides an insight into the specialised services that are currently delivered and the services to be rolled out over the coming years. The following are of relevance to cancer: Upgrading radiotherapy equipment – £130 million had been committed to ‘the biggest upgrade in NHS cancer treatment in […]

read more

Management of renal medullary carcinoma

Renal medullary carcinoma is a very rare subtype of renal cell carcinoma. This is a very devastating tumour, and it affects mostly patients of African descent, and patients with the sickle-cell trait. These patients in general have a survival of about one year from diagnosis, which is very devastating in this typically young patient population. […]

read more
Showing all 3 results